Tina Jovanovic Zinck DrSc, MSc

Tina Zinck joined Novo Nordisk in 2013 where she as a Regulatory Project Manager contributes to the development of new biopharmaceuticals within obesity and type 2 diabetes mellitus. Prior to joining Novo Nordisk she worked as a Non-clinical Assessor for nine years at the Danish Health and Medicines Agency where she was responsible for assessing the non-clinical part of marketing authorisation applications and providing national as well as CHMP non-clinical scientific advice. During her years at the Danish authority she was the Danish representative at the CHMP Safety Working Party. She holds a Ph.D. in pharmacology and a M.Sc. in Human Biology.